Cached score snapshot

US.A · Agilent Technologies

110分制 65.5/110;5D動能v2 6/50;排序分 71.5/160

Ranking score 71.5/160
Main score 65.5/110
5D momentum v2 6/50
Rank #122
Setup grade F 32.3

Score breakdown

觀望

Medium twelvedata

Score and price trend

F 32.3 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 04-10 07-14 07-27 08-06 08-18 $104.70$131.16$157.63 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 3.07 · anchors 120 +0.25% -1.68% / +2.78% 53.6% 2% Actual +2.40% · vs median +2.15% · inside 25-75 band
30D observation +5.43% -1.02% / +11.03% 72% 14.2% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +0.36% -1.69% / +3.34% 54.4% 3.1% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。

2026-04-10 → 2026-08-18 · 409 archived points · 2 Improving turn signal · 6 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 71.5
Display grade 觀望
Model version cursor_18_27_news_v2_160
Main score 65.5/110 (觀望)
5D momentum v2 6/50 (弱)
Score with momentum v2 71.5/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 130.8645
ma50 123.9742
close 131.14
prevClose 130.6
avgVolume20 2310072
volumeRatio 1.06
changePercent 0.41

Metrics snapshot

close 131.14
volume 2443946
changePercent 0.41

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 65.5/110
Main rating 觀望
5D momentum v2 6/50
Score with momentum v2 71.5/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.6/5 · 良好

Dimension score 3.6/5
Dimension grade 良好

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.75
debtPoints 0.5
marginPoints 0.6
turnoverUsdM 320.4991
volumePoints 0.5
revenuePoints 0
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 12.4/20 · 一般

Dimension score 12.4/20
Dimension grade 一般

Sub-items

cmfPoints 0.8
mfiPoints 3.2
obvPoints 4
vwapPoints 2.4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.A
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 10.2/15 · 一般

Dimension score 10.2/15
Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.57

trend

score 2.4

details

qqq

ma20 720.433
ma50 711.664
name QQQ
close 709.43
points 0.4

spy

ma20 741.2935
ma50 739.0122
name SPY
close 747.71
points 2
source twelvedata+fred
atrPct 2.9521
atrPoints 3
cciPoints 2.4
vixPoints 2.4
marketTrendPoints 2.4

催化劑 — 10/20 · 較差

Dimension score 10/20
Dimension grade 較差

Sub-items

catalyst

score 10

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 2
catalystPoints 10

風險管理 — 6.8/10 · 一般

Dimension score 6.8/10
Dimension grade 一般

Sub-items

position

score 1.6

details

atrPct 2.9521
turnoverUsdM 320.4991
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.A
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 123.3972

strength_details

ma_score 1.5
atr_score 2
rsi_score 2
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 5.9
take_profit_price 139.8442
target_multiplier 1.9
technical_strength 1.78
take_profit_percent 6.6
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.9042
diversificationPoints 2

技術信號 — 18.5/30 · 一般

Dimension score 18.5/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 1.2
vcpPoints 2.2
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 2.2
vcp_reason 波幅收縮(22.9%→10%);跌縮量(近10日3日);站上MA50;Ready=Y;Confirm=N

vcp_metrics

up_days 5
vol_ref 2614766.6667
down_days 3
vcp_ready true
above_ma50 true
avg_vol_10 2271820
avg_vol_20 2297930
avg_vol_30 2614766.6667
range_pct_10 0.0996
range_pct_20 0.1167
range_pct_30 0.229
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok true
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 0.8688
dist_to_20d_high 0.0565
down_shrink_days 3
breakout_level_20d 139
vcp_breakout_confirm false
contraction_ratio_10_30 0.4349
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 1.2

情緒分析 — 4/10 · 較差

Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 3
sentimentScoreRaw 0.9

sentimentData

raw {"id":140835525,"url":"https://finnhub.io/api/news?id=94b0899fa78390fbc58321c8109277f99f9fb5c37ef3cee2fd78ff7abbb2a8dd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies stock presents a clear valuation split right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based market multiples imply the shares are already pricing in a lot of good news. Over the past 3 years, Agilent Technologies has returned 12.9%, which suggests the stock has rewarded patient holders but not in a way that obviously rules out further value questions. The recent launch of the AI powered xCELLigence RTCA...","category":"company","datetime":1783455830,"headline":"Agilent (A) Stock Looks Below Fair Value On Cash Flow"}, {"id":140738183,"url":"https://finnhub.io/api/news?id=66b65a87291865a86210f530a1b00adfaff915b2f4a95dc1db2427405312990b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1782487802,"headline":"Why Is Agilent (A) Up 0.1% Since Last Earnings Report?"}, {"id":140730497,"url":"https://finnhub.io/api/news?id=2aa7cdf7d5e75d552f598f1791581a5b2b53b2d36a27b8801fdb7ebd06341efe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.","category":"company","datetime":1782426350,"headline":"Agilent (A) Stock Trades Up, Here Is Why"}, {"id":140724811,"url":"https://finnhub.io/api/news?id=0e4cc50bc9c905e51c1ebc6c5744a1851e863bbd5b1fe193a9a6f7a16c231290","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks. TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and established a $150.00 price target. The firm initiated coverage of the […]","category":"company","datetime":1782391326,"headline":"Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler"}, {"id":140717096,"url":"https://finnhub.io/api/news?id=94b7d0bff663500e008b569194f7c24b2393b2c6331878775fce6236aef3dfc1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately USD 28.94 Billion in 2025 and is expected to reach USD 31.47 Billion in 2026 and is expected to reach around USD 62.83 Billion by 2035, at a CAGR of 8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scien","category":"company","datetime":1782329400,"headline":"Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"}, {"id":140692762,"url":"https://finnhub.io/api/news?id=917ce303d946f6be6809d73ad357e9a862053a1e7f6654f325fd874162d000ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Investors need to pay close attention to A stock based on the movements in the options market lately.","category":"company","datetime":1782135600,"headline":"Is the Options Market Predicting a Spike in Agilent Technologies Stock?"}, {"id":140684374,"url":"https://finnhub.io/api/news?id=423fd7f539c0dd144d7773d5fabf13d92fd8526c319a7deb25d21eccf8225936","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (A) has been in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings. The company raised full-year guidance and paired that update with expansion moves in China and cancer diagnostics. See our latest analysis for Agilent Technologies. Agilent Technologies' latest earnings beat and guidance raise have arrived alongside a 10.53% 1 month share price return and a 13.43% 3 month share price return. The stock's year to date...","category":"company","datetime":1782036497,"headline":"Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise"}, {"id":140683597,"url":"https://finnhub.io/api/news?id=cb943124bc351246470ad2080faee04c8f4124540a363079401b8ffba4701ec2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies recently reported stronger-than-expected Q1 and Q2 results, raised full-year revenue and EPS guidance, and outlined plans to open a China Innovation Center while acquiring Biocare to broaden its cancer diagnostics capabilities. These developments highlight how Agilent is pairing operational improvements with targeted innovation in AI-driven automation and diagnostics to broaden its laboratory solutions footprint. Next, we will examine how Agilent’s upgraded full-year...","category":"company","datetime":1782021981,"headline":"How Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics"}
raw_source {"id":140835525,"url":"https://finnhub.io/api/news?id=94b0899fa78390fbc58321c8109277f99f9fb5c37ef3cee2fd78ff7abbb2a8dd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies stock presents a clear valuation split right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based market multiples imply the shares are already pricing in a lot of good news. Over the past 3 years, Agilent Technologies has returned 12.9%, which suggests the stock has rewarded patient holders but not in a way that obviously rules out further value questions. The recent launch of the AI powered xCELLigence RTCA...","category":"company","datetime":1783455830,"headline":"Agilent (A) Stock Looks Below Fair Value On Cash Flow"}, {"id":140822551,"url":"https://finnhub.io/api/news?id=cee2ec535267e843a0b8f16ab25239634407c46036ba5069e90df7d6cd04facb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Surplus Solutions LLC (\"Surplus Solutions\"), a portfolio company of NMS Capital (\"NMS\"), announced today the acquisition of DCM BioServices (\"DCM Bio\" or the \"Company\"), a Frederick, Maryland-based provider of laboratory automation maintenance, repair, technical support, and integration solutions. The acquisition expands Surplus Solutions' technical service capabilities and supports the Company's continued growth in the biotechnology, pharmaceutical, and life sciences sectors. Terms of the trans","category":"company","datetime":1783358040,"headline":"Surplus Solutions, an NMS Capital Portfolio Company, Accelerates Technical Service Capabilities; Announces Partnership with DCM BioServices"}, {"id":140821772,"url":"https://finnhub.io/api/news?id=b03b0addb0d7acdbf47fda5c877fd3fee0fe08fe9b79b1b286111a4b4df934d5","image":"","source":"Benzinga","related":"A","summary":"Evercore ISI Group analyst Vijay Kumar maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $144 to $148.","category":"company","datetime":1783336119,"headline":"Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $148"}, {"id":140818525,"url":"https://finnhub.io/api/news?id=e8e67091f2f83771cb62d3ba1db83ca7b564b4ea75343756e5eddb52ce7632de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The global mobile mass spectrometers market is set to grow from USD 1.68 billion in 2026 to USD 2.87 billion by 2031, at a CAGR of 11.3%. This significant growth is driven by the demand for real-time, on-site chemical analysis in diverse industries such as environmental monitoring and defense. Ion sources top market components, with their pivotal role in sampling and analysis. Field-deployable platforms lead the product segment, offering portability essential for immediate results. North America","category":"company","datetime":1783327440,"headline":"Mobile Mass Spectrometers Market by Application, Product Type & Component Global Forecast to 2031"}, {"id":140779657,"url":"https://finnhub.io/api/news?id=27678fa4b44f44e51d5561053a6524bbf641d1fe08cd61da09d690c89e908395","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., July 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to ga","category":"company","datetime":1782907200,"headline":"Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight"}, {"id":140772145,"url":"https://finnhub.io/api/news?id=848c46f2007d6cb833f16d6b8bce3b184f6f2cfe022d47a8a2c58ad0b0ba0d34","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Experienced finance executive joins AdCellerant to support continued growth, operational scale, and long-term financial strategyDENVER, June 30, 2026 (GLOBE NEWSWIRE) -- AdCellerant, a leading digital advertising technology and services company, announced today the appointment of Jonathan Kalstein as Chief Financial Officer, where he will help guide the company’s financial strategy as it expands its platform, partner network, and omnichannel advertising capabilities. Kalstein has held CFO and se","category":"company","datetime":1782824400,"headline":"AdCellerant Appoints Jonathan Kalstein as Chief Financial Officer"}, {"id":140740729,"url":"https://finnhub.io/api/news?id=e2ecfe7423e0385e993151624a54a5d758f2b095b51c5e3aa85f275016df6d8d","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read it here.","category":"company","datetime":1782496544,"headline":"Dividend Champion, Contender, And Challenger Highlights: Week Of June 28"}, {"id":140738183,"url":"https://finnhub.io/api/news?id=66b65a87291865a86210f530a1b00adfaff915b2f4a95dc1db2427405312990b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1782487802,"headline":"Why Is Agilent (A) Up 0.1% Since Last Earnings Report?"}, {"id":140736655,"url":"https://finnhub.io/api/news?id=cf31b7bad58ef09d4aeaa0fd01cd0e336195c11b1e3d76df3faeeb9ee5359867","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.","category":"company","datetime":1782468000,"headline":"Agilent finalizes Biocare Medical takeover"}, {"id":140736938,"url":"https://finnhub.io/api/news?id=705f74c6283473d51455eef5e6f512f623e9f6c39295fc7a0f25df78b27b4083","image":"","source":"Benzinga","related":"A","summary":"Bernstein analyst Eve Burstein reinstates Agilent Technologies (NYSE:A) with a Outperform and announces $155 price target.","category":"company","datetime":1782464369,"headline":"Bernstein Reinstates Outperform on Agilent Technologies, Announces $155 Price Target"}, {"id":140730497,"url":"https://finnhub.io/api/news?id=2aa7cdf7d5e75d552f598f1791581a5b2b53b2d36a27b8801fdb7ebd06341efe","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.","category":"company","datetime":1782426350,"headline":"Agilent (A) Stock Trades Up, Here Is Why"}, {"id":140724811,"url":"https://finnhub.io/api/news?id=0e4cc50bc9c905e51c1ebc6c5744a1851e863bbd5b1fe193a9a6f7a16c231290","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks. TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and established a $150.00 price target. The firm initiated coverage of the […]","category":"company","datetime":1782391326,"headline":"Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler"}, {"id":140724812,"url":"https://finnhub.io/api/news?id=3466c5935286f321089f71325848a2db1a0436e56974a775d2665939ef8deec5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical (\"Biocare\"), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. (\"","category":"company","datetime":1782389160,"headline":"Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies"}, {"id":140724813,"url":"https://finnhub.io/api/news?id=8bcad38bea13080efc11b2f7f296246dcd49219a39c4571b8b0e97be6f2de234","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"SANTA CLARA, Calif., June 25, 2026--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.","category":"company","datetime":1782388800,"headline":"Agilent Completes Acquisition of Biocare Medical"}, {"id":140724303,"url":"https://finnhub.io/api/news?id=b57611ff77fa1e0abbc44541bd9e9b8b6b4070cbf01bc0a0d2468b6b47f059ae","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1405583561/image_1405583561.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Equity markets are at historically high valuations, with the Shiller CAPE near dot-com bubble territory and broad market indices showing stretched multiples.","category":"company","datetime":1782378900,"headline":"2 Preferred Shares Paying 7%+ When The Market Panics"}, {"id":140717096,"url":"https://finnhub.io/api/news?id=94b7d0bff663500e008b569194f7c24b2393b2c6331878775fce6236aef3dfc1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately USD 28.94 Billion in 2025 and is expected to reach USD 31.47 Billion in 2026 and is expected to reach around USD 62.83 Billion by 2035, at a CAGR of 8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scien","category":"company","datetime":1782329400,"headline":"Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"}, {"id":140712670,"url":"https://finnhub.io/api/news?id=ef0fee1e42e64e8a18bc4c69f26b54f40fad3706a9dfdf777f5060462e4f9234","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1148805607/image_1148805607.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Read this month's roundup of news for lithium miners here.","category":"company","datetime":1782293790,"headline":"Lithium Miners News For The Month Of June 2026"}, {"id":140692762,"url":"https://finnhub.io/api/news?id=917ce303d946f6be6809d73ad357e9a862053a1e7f6654f325fd874162d000ba","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Investors need to pay close attention to A stock based on the movements in the options market lately.","category":"company","datetime":1782135600,"headline":"Is the Options Market Predicting a Spike in Agilent Technologies Stock?"}, {"id":140684374,"url":"https://finnhub.io/api/news?id=423fd7f539c0dd144d7773d5fabf13d92fd8526c319a7deb25d21eccf8225936","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (A) has been in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings. The company raised full-year guidance and paired that update with expansion moves in China and cancer diagnostics. See our latest analysis for Agilent Technologies. Agilent Technologies' latest earnings beat and guidance raise have arrived alongside a 10.53% 1 month share price return and a 13.43% 3 month share price return. The stock's year to date...","category":"company","datetime":1782036497,"headline":"Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise"}, {"id":140683597,"url":"https://finnhub.io/api/news?id=cb943124bc351246470ad2080faee04c8f4124540a363079401b8ffba4701ec2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies recently reported stronger-than-expected Q1 and Q2 results, raised full-year revenue and EPS guidance, and outlined plans to open a China Innovation Center while acquiring Biocare to broaden its cancer diagnostics capabilities. These developments highlight how Agilent is pairing operational improvements with targeted innovation in AI-driven automation and diagnostics to broaden its laboratory solutions footprint. Next, we will examine how Agilent’s upgraded full-year...","category":"company","datetime":1782021981,"headline":"How Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics"}, {"id":140678738,"url":"https://finnhub.io/api/news?id=1da03ce5ff74bd525c52726b7931ab348915e1c9d7b199f1e543940d87fa876b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies (NYSE:A) plans to open a new China Innovation Center focused on digital, AI, and automation research and development. The company also announced the acquisition of Biocare to expand its presence in cancer diagnostics. These initiatives mark an expansion into areas tied to advanced technology and healthcare testing. Agilent Technologies enters this phase of expansion with its stock trading at $127.06 and a value score of 5. The share price is up 10.7% over the past 30...","category":"company","datetime":1781968032,"headline":"Agilent (A) Opens China Innovation Center And Buys Biocare For Cancer Diagnostics"}, {"id":140673919,"url":"https://finnhub.io/api/news?id=fdde15b4423c2cf203007b7fb1f14b7b979bc514e99f774480e99506aaacede9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at research tools & consumables stocks, starting with Agilent (NYSE:A).","category":"company","datetime":1781901418,"headline":"Research Tools & Consumables Stocks Q1 Results: Benchmarking Agilent (NYSE:A)"}, {"id":140670094,"url":"https://finnhub.io/api/news?id=953bd1087ca779f2e38815783c5351db21160739bea33debc89424a470f32ca2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.","category":"company","datetime":1781872203,"headline":"Here's How Much a $1000 Investment in Keysight Made 10 Years Ago Would Be Worth Today"}, {"id":140667362,"url":"https://finnhub.io/api/news?id=ec014911efb445fb9717ade9fb866f9537ac2b60494bdc533db109c97928b339","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Automated Liquid Handling Systems Market size & share revenue was valued at approximately USD 2.7 Billion in 2025 and is expected to reach USD 2.9 Billion in 2026 and is expected to reach around USD 6.9 Billion by 2035, at a CAGR of 9.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Eppendorf SE, Perki","category":"company","datetime":1781836200,"headline":"Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"}, {"id":140662627,"url":"https://finnhub.io/api/news?id=e8a4e240743cd0e80e6968416de85b3dc4b87ae3f3ae7ea8f6fb09cea65bdda3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.","category":"company","datetime":1781791048,"headline":"3 Large-Cap Stocks We Keep Off Our Radar"}, {"id":140663719,"url":"https://finnhub.io/api/news?id=083b7720894b5a2b17d1bba9fc0ec578dae9614f18ced4cfd3bfea0b17d9d382","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2246668252/image_2246668252.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"A","summary":"Twist Bioscience (TWST) looks overvalued at 11x revenue with ongoing losses; our fair value is $38 (50% downside). Read more macro analysis here.","category":"company","datetime":1781787684,"headline":"Twist Bioscience: Huge Downside, With Little Hope Of Profits"}, {"id":140657316,"url":"https://finnhub.io/api/news?id=bb0ef7d99e16699207d83bd1af629a955cc977b038dbdb9e33cff98f1259b566","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was valued at approximately USD 1.14 Billion in 2025 and is expected to reach USD 1.23 Billion in 2026 and is expected to reach around USD 2.27 Billion by 2035, at a CAGR of 7.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fis","category":"company","datetime":1781728200,"headline":"Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"}, {"id":140655717,"url":"https://finnhub.io/api/news?id=64dacef5a9e6079150b086c84ce7dd1b74829f20592a494c1aba849317e67025","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Waters Corporation has lagged behind the broader health care sector over the past year, but analysts remain fairly bullish about its future prospects.","category":"company","datetime":1781701162,"headline":"Waters Corporation Stock: Is WAT Underperforming the Health Care Sector?"}, {"id":140657464,"url":"https://finnhub.io/api/news?id=486f5a7b9569f3c2d96a609374b3e02ae16737ccd2a582c884bcda130a22ef33","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=2048&height=1536","source":"Benzinga","related":"A","summary":" ","category":"company","datetime":1781671653,"headline":"Agilent Technologies Q2 2026 Earnings Call: Complete Transcript"}, {"id":140645102,"url":"https://finnhub.io/api/news?id=473804a537fe1a68c803ba62c36a282b6ee2af0706b3184ac14b376afd1f19cf","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Madison Investments, an investment advisor, released its first-quarter 2026 investor letter for the “Madison Large Cap Fund”. A copy of the letter is available to download here. The Madison Large Cap Fund (Class I) declined 2.7% in the quarter, outperforming the S&P 500’s -4.33% return. The fund focuses on long-term capital appreciation. The quarter saw […]","category":"company","datetime":1781615764,"headline":"Madison Large Cap Fund Maintains Position on Agilent Technologies (A) Amid AI Fears"}, {"id":140644862,"url":"https://finnhub.io/api/news?id=9aff2d3429d69b1e2718ee83f6ddfd75445834144fd257eaaf7fe5c266c4f342","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.","category":"company","datetime":1781611744,"headline":"1 Profitable Stock to Target This Week and 2 We Avoid"}, {"id":140621797,"url":"https://finnhub.io/api/news?id=134fba6508c40ad8f596f1a9a552083bc7cc635494ac976c0eed8f90ca62654a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"ROP's Technology Enabled Products segment is benefiting from medical product demand, helping support its 2026 growth outlook.","category":"company","datetime":1781289600,"headline":"Strength in Technology Enabled Products Drives Roper: Can the Momentum Sustain?"}, {"id":140616170,"url":"https://finnhub.io/api/news?id=32fd5b4435bcdf78fc3b818d7a4ff1f06b39713aac9c096652bd7c9c6b263ca1","image":"https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp","source":"ChartMill","related":"A","summary":"Agilent Technologies passes the Caviar Cruise quality screen, showing strong profitability, 31.9% ROIC, and solid financial health. Discover why this stock suits long-term buy-and-hold investors.","category":"company","datetime":1781259038,"headline":"Agilent Technologies Inc (NYSE:A): A Quality Growth Play Passes the ‘Caviar Cruise’ Screen"}, {"id":140613570,"url":"https://finnhub.io/api/news?id=36429881d1ac3070da557aaeb03cd070afbcd3c3ebdc6c18568583aaf050e3c9","image":"","source":"Fintel","related":"A","summary":"","category":"company","datetime":1781222601,"headline":"Piper Sandler Initiates Coverage of Agilent Technologies (A) with Neutral Recommendation"}, {"id":139835603,"url":"https://finnhub.io/api/news?id=953fd7c963e0c5c7fefec12d69c7c78db5d8c24be2387123c7a503f0a80f1920","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Intel upgraded, Reddit initiated: Wall Street's top analyst calls","category":"company","datetime":1781185111,"headline":"Intel upgraded, Reddit initiated: Wall Street's top analyst calls"}, {"id":140605365,"url":"https://finnhub.io/api/news?id=af7230640ae3fae9d50ff45abd4f7dea95d989dc6169f8054b731ea8dcfcd4dc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued at approximately USD 6.8 Billion in 2025 and is expected to reach USD 8.3 Billion in 2026 and is expected to reach around USD 56.1 Billion by 2035, at a CAGR of 23.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc.,","category":"company","datetime":1781173800,"headline":"Global Next Generation Sequencing Services Market Size/Share Worth USD 56.1 Billion by 2035 at a 23.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"}, {"id":140611383,"url":"https://finnhub.io/api/news?id=fc9b952042a6ef4519293255683bedb282fc803010b7f3e7532f8053157aa745","image":"","source":"Benzinga","related":"A","summary":"Piper Sandler analyst David Westenberg initiates coverage on Agilent Technologies (NYSE:A) with a Neutral rating and announces Price Target of $150.","category":"company","datetime":1781159639,"headline":"Piper Sandler Initiates Coverage On Agilent Technologies with Neutral Rating, Announces Price Target of $150"}, {"id":140590958,"url":"https://finnhub.io/api/news?id=d9a1d8bbd718642bf610adbc2aa9c44156ce8db3d96705833144a6828d6a2290","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"Agilent Technologies has outperformed the Nasdaq recently, and analysts remain highly optimistic about the stock’s prospects.","category":"company","datetime":1781050197,"headline":"Is Agilent Technologies Stock Outperforming the Nasdaq?"}, {"id":140586969,"url":"https://finnhub.io/api/news?id=033bf13a5768598db1be264f18f398974e3a1ef1a538c2a0ff9a49bef733aba0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"IQVIA Holdings has outperformed the Dow over the past year, and analysts are highly optimistic about the stock’s prospects.","category":"company","datetime":1781013738,"headline":"Is IQVIA Holdings Stock Outperforming the Dow?"}, {"id":140580383,"url":"https://finnhub.io/api/news?id=7df70abe787638f04f17343bf16d880b6f2c8deae93f36880613db80af5bb880","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"A","summary":"The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...","category":"company","datetime":1781010009,"headline":"Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 3
recomputed_at_score true
sentiment_score_raw 0.9
source_article_count 40
discarded_article_count 22
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.6 5/110 72% 3.6
資金流 12.4 20/110 62% 12.4
市場環境 10.2 15/110 68% 10.2
催化劑 10 20/110 50% 10
風險管理 6.8 10/110 68% 6.8
技術信號 18.5 30/110 61.67% 18.5
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 6/50
ret_5d -0.0127
max_score 50
max_total 50
raw_total 6
vcp_bonus 0
vol_ratio 1.0635
ret_points 0
vol_points 2
range_ratio 0.7695
volat_points 0
day_range_pct 0.0214
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 4
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.9521
turnoverUsdM 320.4991
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.A
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 123.3972

strength_details

ma_score 1.5
atr_score 2
rsi_score 2
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 5.9
take_profit_price 139.8442
target_multiplier 1.9
technical_strength 1.78
take_profit_percent 6.6
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.9042
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.6/5分
資金流分析總分: 12.4/20分
市場環境分析總分: 10.2/15分
催化劑分析: 10/20分
風險管理總分: 6.8/10分
技術信號分析總分: 18.5/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 85.71
atr
atr 3.8714
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.95
cci
rule Cursor_18.24 CCI bands
level 平衡
score 6
value 2.92
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.1863
kdj
d 49.52
j 25.22
k 41.42
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 入貨中
score 8
value 62.32
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 10
trend 強流入
value 33450846
recentSlope 660274.6
previousSlope 155790
rsi
value 51.05
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 137.3462
position SAR喺價上
distancePct 4.73
previousTrend 下降
ma50
value 123.9742
macd
macd 1.8287
trend 中性偏多
signal 2.3076
histogram -0.4789
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 6
value 131.0225
position 連續1-2日>VWAP
consecutiveAbove 1
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.06
score 6
avgVolume 2310072
currentVolume 2443946
derived
ma20 130.8645
ma50 123.9742
prevClose 130.6
avgVolume10 2297505
avgVolume20 2310072
changePercent 0.41
avgVolumeForScore 2310072
ma_cross
ma20 130.8645
ma50 123.9742
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 131.0795
prevMa50 123.6398
spreadPct 5.56
isVolumeBreakout false
bollinger
lower 124.6797
upper 137.0493
position 上半部
rsi_short
value 15.56
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.06

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.9521122464541714,
        "turnoverUsdM": 320.49907843999995,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.A",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 123.3972,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 5.9,
      "take_profit_price": 139.8442,
      "target_multiplier": 1.9,
      "technical_strength": 1.78,
      "take_profit_percent": 6.6
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.904224492908343,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 71.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 65.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 6
  },
  "market": {
    "ma20": 130.8645,
    "ma50": 123.9742,
    "close": 131.14,
    "prevClose": 130.6,
    "avgVolume20": 2310072,
    "volumeRatio": 1.06,
    "changePercent": 0.41
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 6,
    "details": {
      "ret_5d": -0.01272302943612158,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 6,
      "vcp_bonus": 0,
      "vol_ratio": 1.063542405556305,
      "ret_points": 0,
      "vol_points": 2,
      "range_ratio": 0.7694897429622789,
      "volat_points": 0,
      "day_range_pct": 0.021350388897361423,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 4,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 71.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 72,
        "contribution": 3.6
      },
      {
        "raw": 12.4,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 62,
        "contribution": 12.4
      },
      {
        "raw": 10.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 68,
        "contribution": 10.2
      },
      {
        "raw": 10,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 18.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 61.67,
        "contribution": 18.5
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 65.5,
    "details": [
      "基本面分析總分: 3.6/5分",
      "資金流分析總分: 12.4/20分",
      "市場環境分析總分: 10.2/15分",
      "催化劑分析: 10/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 18.5/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 10,
      "基本面": 3.6,
      "資金流": 12.4,
      "市場環境": 10.2,
      "情緒分析": 4,
      "技術信號": 18.5,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 10,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 2
            }
          },
          "catalystPoints": 10
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.6,
          "turnoverUsdM": 320.49907843999995,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 3.2,
          "obvPoints": 4,
          "vwapPoints": 2.4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.A",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.57
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 720.4330052000001,
                "ma50": 711.66400144,
                "name": "QQQ",
                "close": 709.42999,
                "points": 0.4
              },
              "spy": {
                "ma20": 741.2935059,
                "ma50": 739.0122021000002,
                "name": "SPY",
                "close": 747.71002,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.9521122464541714,
          "atrPoints": 3,
          "cciPoints": 2.4,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140835525,
                "url": "https://finnhub.io/api/news?id=94b0899fa78390fbc58321c8109277f99f9fb5c37ef3cee2fd78ff7abbb2a8dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies stock presents a clear valuation split right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based market multiples imply the shares are already pricing in a lot of good news. Over the past 3 years, Agilent Technologies has returned 12.9%, which suggests the stock has rewarded patient holders but not in a way that obviously rules out further value questions. The recent launch of the AI powered xCELLigence RTCA...",
                "category": "company",
                "datetime": 1783455830,
                "headline": "Agilent (A) Stock Looks Below Fair Value On Cash Flow"
              },
              {
                "id": 140738183,
                "url": "https://finnhub.io/api/news?id=66b65a87291865a86210f530a1b00adfaff915b2f4a95dc1db2427405312990b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1782487802,
                "headline": "Why Is Agilent (A) Up 0.1% Since Last Earnings Report?"
              },
              {
                "id": 140730497,
                "url": "https://finnhub.io/api/news?id=2aa7cdf7d5e75d552f598f1791581a5b2b53b2d36a27b8801fdb7ebd06341efe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.",
                "category": "company",
                "datetime": 1782426350,
                "headline": "Agilent (A) Stock Trades Up, Here Is Why"
              },
              {
                "id": 140724811,
                "url": "https://finnhub.io/api/news?id=0e4cc50bc9c905e51c1ebc6c5744a1851e863bbd5b1fe193a9a6f7a16c231290",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks. TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and established a $150.00 price target. The firm initiated coverage of the […]",
                "category": "company",
                "datetime": 1782391326,
                "headline": "Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler"
              },
              {
                "id": 140717096,
                "url": "https://finnhub.io/api/news?id=94b7d0bff663500e008b569194f7c24b2393b2c6331878775fce6236aef3dfc1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately USD 28.94 Billion in 2025 and is expected to reach USD 31.47 Billion in 2026 and is expected to reach around USD 62.83 Billion by 2035, at a CAGR of 8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scien",
                "category": "company",
                "datetime": 1782329400,
                "headline": "Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"
              },
              {
                "id": 140692762,
                "url": "https://finnhub.io/api/news?id=917ce303d946f6be6809d73ad357e9a862053a1e7f6654f325fd874162d000ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Investors need to pay close attention to A stock based on the movements in the options market lately.",
                "category": "company",
                "datetime": 1782135600,
                "headline": "Is the Options Market Predicting a Spike in Agilent Technologies Stock?"
              },
              {
                "id": 140684374,
                "url": "https://finnhub.io/api/news?id=423fd7f539c0dd144d7773d5fabf13d92fd8526c319a7deb25d21eccf8225936",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (A) has been in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings. The company raised full-year guidance and paired that update with expansion moves in China and cancer diagnostics. See our latest analysis for Agilent Technologies. Agilent Technologies' latest earnings beat and guidance raise have arrived alongside a 10.53% 1 month share price return and a 13.43% 3 month share price return. The stock's year to date...",
                "category": "company",
                "datetime": 1782036497,
                "headline": "Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise"
              },
              {
                "id": 140683597,
                "url": "https://finnhub.io/api/news?id=cb943124bc351246470ad2080faee04c8f4124540a363079401b8ffba4701ec2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies recently reported stronger-than-expected Q1 and Q2 results, raised full-year revenue and EPS guidance, and outlined plans to open a China Innovation Center while acquiring Biocare to broaden its cancer diagnostics capabilities. These developments highlight how Agilent is pairing operational improvements with targeted innovation in AI-driven automation and diagnostics to broaden its laboratory solutions footprint. Next, we will examine how Agilent’s upgraded full-year...",
                "category": "company",
                "datetime": 1782021981,
                "headline": "How Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics"
              }
            ],
            "raw_source": [
              {
                "id": 140835525,
                "url": "https://finnhub.io/api/news?id=94b0899fa78390fbc58321c8109277f99f9fb5c37ef3cee2fd78ff7abbb2a8dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies stock presents a clear valuation split right now, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while earnings-based market multiples imply the shares are already pricing in a lot of good news. Over the past 3 years, Agilent Technologies has returned 12.9%, which suggests the stock has rewarded patient holders but not in a way that obviously rules out further value questions. The recent launch of the AI powered xCELLigence RTCA...",
                "category": "company",
                "datetime": 1783455830,
                "headline": "Agilent (A) Stock Looks Below Fair Value On Cash Flow"
              },
              {
                "id": 140822551,
                "url": "https://finnhub.io/api/news?id=cee2ec535267e843a0b8f16ab25239634407c46036ba5069e90df7d6cd04facb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Surplus Solutions LLC (\"Surplus Solutions\"), a portfolio company of NMS Capital (\"NMS\"), announced today the acquisition of DCM BioServices (\"DCM Bio\" or the \"Company\"), a Frederick, Maryland-based provider of laboratory automation maintenance, repair, technical support, and integration solutions. The acquisition expands Surplus Solutions' technical service capabilities and supports the Company's continued growth in the biotechnology, pharmaceutical, and life sciences sectors. Terms of the trans",
                "category": "company",
                "datetime": 1783358040,
                "headline": "Surplus Solutions, an NMS Capital Portfolio Company, Accelerates Technical Service Capabilities; Announces Partnership with DCM BioServices"
              },
              {
                "id": 140821772,
                "url": "https://finnhub.io/api/news?id=b03b0addb0d7acdbf47fda5c877fd3fee0fe08fe9b79b1b286111a4b4df934d5",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $144 to $148.",
                "category": "company",
                "datetime": 1783336119,
                "headline": "Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $148"
              },
              {
                "id": 140818525,
                "url": "https://finnhub.io/api/news?id=e8e67091f2f83771cb62d3ba1db83ca7b564b4ea75343756e5eddb52ce7632de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The global mobile mass spectrometers market is set to grow from USD 1.68 billion in 2026 to USD 2.87 billion by 2031, at a CAGR of 11.3%. This significant growth is driven by the demand for real-time, on-site chemical analysis in diverse industries such as environmental monitoring and defense. Ion sources top market components, with their pivotal role in sampling and analysis. Field-deployable platforms lead the product segment, offering portability essential for immediate results. North America",
                "category": "company",
                "datetime": 1783327440,
                "headline": "Mobile Mass Spectrometers Market by Application, Product Type & Component Global Forecast to 2031"
              },
              {
                "id": 140779657,
                "url": "https://finnhub.io/api/news?id=27678fa4b44f44e51d5561053a6524bbf641d1fe08cd61da09d690c89e908395",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., July 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to ga",
                "category": "company",
                "datetime": 1782907200,
                "headline": "Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight"
              },
              {
                "id": 140772145,
                "url": "https://finnhub.io/api/news?id=848c46f2007d6cb833f16d6b8bce3b184f6f2cfe022d47a8a2c58ad0b0ba0d34",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Experienced finance executive joins AdCellerant to support continued growth, operational scale, and long-term financial strategyDENVER, June 30, 2026 (GLOBE NEWSWIRE) -- AdCellerant, a leading digital advertising technology and services company, announced today the appointment of Jonathan Kalstein as Chief Financial Officer, where he will help guide the company’s financial strategy as it expands its platform, partner network, and omnichannel advertising capabilities. Kalstein has held CFO and se",
                "category": "company",
                "datetime": 1782824400,
                "headline": "AdCellerant Appoints Jonathan Kalstein as Chief Financial Officer"
              },
              {
                "id": 140740729,
                "url": "https://finnhub.io/api/news?id=e2ecfe7423e0385e993151624a54a5d758f2b095b51c5e3aa85f275016df6d8d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read it here.",
                "category": "company",
                "datetime": 1782496544,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of June 28"
              },
              {
                "id": 140738183,
                "url": "https://finnhub.io/api/news?id=66b65a87291865a86210f530a1b00adfaff915b2f4a95dc1db2427405312990b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1782487802,
                "headline": "Why Is Agilent (A) Up 0.1% Since Last Earnings Report?"
              },
              {
                "id": 140736655,
                "url": "https://finnhub.io/api/news?id=cf31b7bad58ef09d4aeaa0fd01cd0e336195c11b1e3d76df3faeeb9ee5359867",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.",
                "category": "company",
                "datetime": 1782468000,
                "headline": "Agilent finalizes Biocare Medical takeover"
              },
              {
                "id": 140736938,
                "url": "https://finnhub.io/api/news?id=705f74c6283473d51455eef5e6f512f623e9f6c39295fc7a0f25df78b27b4083",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Bernstein  analyst Eve Burstein   reinstates Agilent Technologies (NYSE:A) with a Outperform and announces $155 price target.",
                "category": "company",
                "datetime": 1782464369,
                "headline": "Bernstein Reinstates Outperform on Agilent Technologies, Announces $155 Price Target"
              },
              {
                "id": 140730497,
                "url": "https://finnhub.io/api/news?id=2aa7cdf7d5e75d552f598f1791581a5b2b53b2d36a27b8801fdb7ebd06341efe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.",
                "category": "company",
                "datetime": 1782426350,
                "headline": "Agilent (A) Stock Trades Up, Here Is Why"
              },
              {
                "id": 140724811,
                "url": "https://finnhub.io/api/news?id=0e4cc50bc9c905e51c1ebc6c5744a1851e863bbd5b1fe193a9a6f7a16c231290",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks. TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and established a $150.00 price target. The firm initiated coverage of the […]",
                "category": "company",
                "datetime": 1782391326,
                "headline": "Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler"
              },
              {
                "id": 140724812,
                "url": "https://finnhub.io/api/news?id=3466c5935286f321089f71325848a2db1a0436e56974a775d2665939ef8deec5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical (\"Biocare\"), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. (\"",
                "category": "company",
                "datetime": 1782389160,
                "headline": "Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies"
              },
              {
                "id": 140724813,
                "url": "https://finnhub.io/api/news?id=8bcad38bea13080efc11b2f7f296246dcd49219a39c4571b8b0e97be6f2de234",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "SANTA CLARA, Calif., June 25, 2026--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.",
                "category": "company",
                "datetime": 1782388800,
                "headline": "Agilent Completes Acquisition of Biocare Medical"
              },
              {
                "id": 140724303,
                "url": "https://finnhub.io/api/news?id=b57611ff77fa1e0abbc44541bd9e9b8b6b4070cbf01bc0a0d2468b6b47f059ae",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1405583561/image_1405583561.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Equity markets are at historically high valuations, with the Shiller CAPE near dot-com bubble territory and broad market indices showing stretched multiples.",
                "category": "company",
                "datetime": 1782378900,
                "headline": "2 Preferred Shares Paying 7%+ When The Market Panics"
              },
              {
                "id": 140717096,
                "url": "https://finnhub.io/api/news?id=94b7d0bff663500e008b569194f7c24b2393b2c6331878775fce6236aef3dfc1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately USD 28.94 Billion in 2025 and is expected to reach USD 31.47 Billion in 2026 and is expected to reach around USD 62.83 Billion by 2035, at a CAGR of 8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scien",
                "category": "company",
                "datetime": 1782329400,
                "headline": "Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"
              },
              {
                "id": 140712670,
                "url": "https://finnhub.io/api/news?id=ef0fee1e42e64e8a18bc4c69f26b54f40fad3706a9dfdf777f5060462e4f9234",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1148805607/image_1148805607.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Read this month's roundup of news for lithium miners here.",
                "category": "company",
                "datetime": 1782293790,
                "headline": "Lithium Miners News For The Month Of June 2026"
              },
              {
                "id": 140692762,
                "url": "https://finnhub.io/api/news?id=917ce303d946f6be6809d73ad357e9a862053a1e7f6654f325fd874162d000ba",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Investors need to pay close attention to A stock based on the movements in the options market lately.",
                "category": "company",
                "datetime": 1782135600,
                "headline": "Is the Options Market Predicting a Spike in Agilent Technologies Stock?"
              },
              {
                "id": 140684374,
                "url": "https://finnhub.io/api/news?id=423fd7f539c0dd144d7773d5fabf13d92fd8526c319a7deb25d21eccf8225936",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (A) has been in focus after reporting quarterly results that exceeded analyst expectations on both revenue and earnings. The company raised full-year guidance and paired that update with expansion moves in China and cancer diagnostics. See our latest analysis for Agilent Technologies. Agilent Technologies' latest earnings beat and guidance raise have arrived alongside a 10.53% 1 month share price return and a 13.43% 3 month share price return. The stock's year to date...",
                "category": "company",
                "datetime": 1782036497,
                "headline": "Agilent Technologies (A) Stock Could Be 23% Undervalued After Earnings Beat And Guidance Raise"
              },
              {
                "id": 140683597,
                "url": "https://finnhub.io/api/news?id=cb943124bc351246470ad2080faee04c8f4124540a363079401b8ffba4701ec2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies recently reported stronger-than-expected Q1 and Q2 results, raised full-year revenue and EPS guidance, and outlined plans to open a China Innovation Center while acquiring Biocare to broaden its cancer diagnostics capabilities. These developments highlight how Agilent is pairing operational improvements with targeted innovation in AI-driven automation and diagnostics to broaden its laboratory solutions footprint. Next, we will examine how Agilent’s upgraded full-year...",
                "category": "company",
                "datetime": 1782021981,
                "headline": "How Investors May Respond To Agilent Technologies (A) Upgraded Outlook And Push Into AI-Powered Diagnostics"
              },
              {
                "id": 140678738,
                "url": "https://finnhub.io/api/news?id=1da03ce5ff74bd525c52726b7931ab348915e1c9d7b199f1e543940d87fa876b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies (NYSE:A) plans to open a new China Innovation Center focused on digital, AI, and automation research and development. The company also announced the acquisition of Biocare to expand its presence in cancer diagnostics. These initiatives mark an expansion into areas tied to advanced technology and healthcare testing. Agilent Technologies enters this phase of expansion with its stock trading at $127.06 and a value score of 5. The share price is up 10.7% over the past 30...",
                "category": "company",
                "datetime": 1781968032,
                "headline": "Agilent (A) Opens China Innovation Center And Buys Biocare For Cancer Diagnostics"
              },
              {
                "id": 140673919,
                "url": "https://finnhub.io/api/news?id=fdde15b4423c2cf203007b7fb1f14b7b979bc514e99f774480e99506aaacede9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at research tools & consumables stocks, starting with Agilent (NYSE:A).",
                "category": "company",
                "datetime": 1781901418,
                "headline": "Research Tools & Consumables Stocks Q1 Results: Benchmarking Agilent (NYSE:A)"
              },
              {
                "id": 140670094,
                "url": "https://finnhub.io/api/news?id=953bd1087ca779f2e38815783c5351db21160739bea33debc89424a470f32ca2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1781872203,
                "headline": "Here's How Much a $1000 Investment in Keysight Made 10 Years Ago Would Be Worth Today"
              },
              {
                "id": 140667362,
                "url": "https://finnhub.io/api/news?id=ec014911efb445fb9717ade9fb866f9537ac2b60494bdc533db109c97928b339",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Automated Liquid Handling Systems Market size & share revenue was valued at approximately USD 2.7 Billion in 2025 and is expected to reach USD 2.9 Billion in 2026 and is expected to reach around USD 6.9 Billion by 2035, at a CAGR of 9.8% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Eppendorf SE, Perki",
                "category": "company",
                "datetime": 1781836200,
                "headline": "Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)"
              },
              {
                "id": 140662627,
                "url": "https://finnhub.io/api/news?id=e8a4e240743cd0e80e6968416de85b3dc4b87ae3f3ae7ea8f6fb09cea65bdda3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.",
                "category": "company",
                "datetime": 1781791048,
                "headline": "3 Large-Cap Stocks We Keep Off Our Radar"
              },
              {
                "id": 140663719,
                "url": "https://finnhub.io/api/news?id=083b7720894b5a2b17d1bba9fc0ec578dae9614f18ced4cfd3bfea0b17d9d382",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2246668252/image_2246668252.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "A",
                "summary": "Twist Bioscience (TWST) looks overvalued at 11x revenue with ongoing losses; our fair value is $38 (50% downside). Read more macro analysis here.",
                "category": "company",
                "datetime": 1781787684,
                "headline": "Twist Bioscience: Huge Downside, With Little Hope Of Profits"
              },
              {
                "id": 140657316,
                "url": "https://finnhub.io/api/news?id=bb0ef7d99e16699207d83bd1af629a955cc977b038dbdb9e33cff98f1259b566",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was valued at approximately USD 1.14 Billion in 2025 and is expected to reach USD 1.23 Billion in 2026 and is expected to reach around USD 2.27 Billion by 2035, at a CAGR of 7.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Thermo Fis",
                "category": "company",
                "datetime": 1781728200,
                "headline": "Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 140655717,
                "url": "https://finnhub.io/api/news?id=64dacef5a9e6079150b086c84ce7dd1b74829f20592a494c1aba849317e67025",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Waters Corporation has lagged behind the broader health care sector over the past year, but analysts remain fairly bullish about its future prospects.",
                "category": "company",
                "datetime": 1781701162,
                "headline": "Waters Corporation Stock: Is WAT Underperforming the Health Care Sector?"
              },
              {
                "id": 140657464,
                "url": "https://finnhub.io/api/news?id=486f5a7b9569f3c2d96a609374b3e02ae16737ccd2a582c884bcda130a22ef33",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "A",
                "summary": " ",
                "category": "company",
                "datetime": 1781671653,
                "headline": "Agilent Technologies Q2 2026 Earnings Call: Complete Transcript"
              },
              {
                "id": 140645102,
                "url": "https://finnhub.io/api/news?id=473804a537fe1a68c803ba62c36a282b6ee2af0706b3184ac14b376afd1f19cf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Madison Investments, an investment advisor, released its first-quarter 2026 investor letter for the “Madison Large Cap Fund”. A copy of the letter is available to download here. The Madison Large Cap Fund (Class I) declined 2.7% in the quarter, outperforming the S&P 500’s -4.33% return. The fund focuses on long-term capital appreciation. The quarter saw […]",
                "category": "company",
                "datetime": 1781615764,
                "headline": "Madison Large Cap Fund Maintains Position on Agilent Technologies (A) Amid AI Fears"
              },
              {
                "id": 140644862,
                "url": "https://finnhub.io/api/news?id=9aff2d3429d69b1e2718ee83f6ddfd75445834144fd257eaaf7fe5c266c4f342",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
                "category": "company",
                "datetime": 1781611744,
                "headline": "1 Profitable Stock to Target This Week and 2 We Avoid"
              },
              {
                "id": 140621797,
                "url": "https://finnhub.io/api/news?id=134fba6508c40ad8f596f1a9a552083bc7cc635494ac976c0eed8f90ca62654a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "ROP's Technology Enabled Products segment is benefiting from medical product demand, helping support its 2026 growth outlook.",
                "category": "company",
                "datetime": 1781289600,
                "headline": "Strength in Technology Enabled Products Drives Roper: Can the Momentum Sustain?"
              },
              {
                "id": 140616170,
                "url": "https://finnhub.io/api/news?id=32fd5b4435bcdf78fc3b818d7a4ff1f06b39713aac9c096652bd7c9c6b263ca1",
                "image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
                "source": "ChartMill",
                "related": "A",
                "summary": "Agilent Technologies passes the Caviar Cruise quality screen, showing strong profitability, 31.9% ROIC, and solid financial health. Discover why this stock suits long-term buy-and-hold investors.",
                "category": "company",
                "datetime": 1781259038,
                "headline": "Agilent Technologies Inc (NYSE:A): A Quality Growth Play Passes the ‘Caviar Cruise’ Screen"
              },
              {
                "id": 140613570,
                "url": "https://finnhub.io/api/news?id=36429881d1ac3070da557aaeb03cd070afbcd3c3ebdc6c18568583aaf050e3c9",
                "image": "",
                "source": "Fintel",
                "related": "A",
                "summary": "",
                "category": "company",
                "datetime": 1781222601,
                "headline": "Piper Sandler Initiates Coverage of Agilent Technologies (A) with Neutral Recommendation"
              },
              {
                "id": 139835603,
                "url": "https://finnhub.io/api/news?id=953fd7c963e0c5c7fefec12d69c7c78db5d8c24be2387123c7a503f0a80f1920",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Intel upgraded, Reddit initiated: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1781185111,
                "headline": "Intel upgraded, Reddit initiated: Wall Street's top analyst calls"
              },
              {
                "id": 140605365,
                "url": "https://finnhub.io/api/news?id=af7230640ae3fae9d50ff45abd4f7dea95d989dc6169f8054b731ea8dcfcd4dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued at approximately USD 6.8 Billion in 2025 and is expected to reach USD 8.3 Billion in 2026 and is expected to reach around USD 56.1 Billion by 2035, at a CAGR of 23.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc.,",
                "category": "company",
                "datetime": 1781173800,
                "headline": "Global Next Generation Sequencing Services Market Size/Share Worth USD 56.1 Billion by 2035 at a 23.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)"
              },
              {
                "id": 140611383,
                "url": "https://finnhub.io/api/news?id=fc9b952042a6ef4519293255683bedb282fc803010b7f3e7532f8053157aa745",
                "image": "",
                "source": "Benzinga",
                "related": "A",
                "summary": "Piper Sandler  analyst David Westenberg   initiates coverage on Agilent Technologies (NYSE:A) with a Neutral rating and announces Price Target of $150.",
                "category": "company",
                "datetime": 1781159639,
                "headline": "Piper Sandler Initiates Coverage On Agilent Technologies with Neutral Rating, Announces Price Target of $150"
              },
              {
                "id": 140590958,
                "url": "https://finnhub.io/api/news?id=d9a1d8bbd718642bf610adbc2aa9c44156ce8db3d96705833144a6828d6a2290",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "Agilent Technologies has outperformed the Nasdaq recently, and analysts remain highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1781050197,
                "headline": "Is Agilent Technologies Stock Outperforming the Nasdaq?"
              },
              {
                "id": 140586969,
                "url": "https://finnhub.io/api/news?id=033bf13a5768598db1be264f18f398974e3a1ef1a538c2a0ff9a49bef733aba0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "IQVIA Holdings has outperformed the Dow over the past year, and analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1781013738,
                "headline": "Is IQVIA Holdings Stock Outperforming the Dow?"
              },
              {
                "id": 140580383,
                "url": "https://finnhub.io/api/news?id=7df70abe787638f04f17343bf16d880b6f2c8deae93f36880613db80af5bb880",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "A",
                "summary": "The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...",
                "category": "company",
                "datetime": 1781010009,
                "headline": "Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 40,
            "discarded_article_count": 22
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.5,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(22.9%→10%);跌縮量(近10日3日);站上MA50;Ready=Y;Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 2614766.6666666665,
              "down_days": 3,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 2271820,
              "avg_vol_20": 2297930,
              "avg_vol_30": 2614766.6666666665,
              "range_pct_10": 0.0995882263230136,
              "range_pct_20": 0.11666920847948756,
              "range_pct_30": 0.22899190178435277,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8688423441224838,
              "dist_to_20d_high": 0.056546762589928155,
              "down_shrink_days": 3,
              "breakout_level_20d": 139,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.43489846386270137
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.9521122464541714,
              "turnoverUsdM": 320.49907843999995,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.A",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 123.3972,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 5.9,
            "take_profit_price": 139.8442,
            "target_multiplier": 1.9,
            "technical_strength": 1.78,
            "take_profit_percent": 6.6
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.904224492908343,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 85.71,
    "atr": {
      "atr": 3.8714,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.95
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 2.92
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1863
    },
    "kdj": {
      "d": 49.52,
      "j": 25.22,
      "k": 41.42,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 62.32
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 33450846,
      "recentSlope": 660274.6,
      "previousSlope": 155790
    },
    "rsi": 51.05,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 137.3462,
      "position": "SAR喺價上",
      "distancePct": 4.73,
      "previousTrend": "下降"
    },
    "ma50": 123.9742,
    "macd": {
      "macd": 1.8287421707279918,
      "trend": "中性偏多",
      "signal": 2.3076420299886635,
      "histogram": -0.4788998592606717
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 6,
      "value": 131.0225,
      "position": "連續1-2日>VWAP",
      "consecutiveAbove": 1
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.06,
      "score": 6,
      "avgVolume": 2310072,
      "currentVolume": 2443946
    },
    "derived": {
      "ma20": 130.8645,
      "ma50": 123.9742,
      "prevClose": 130.6,
      "avgVolume10": 2297505,
      "avgVolume20": 2310072,
      "changePercent": 0.41,
      "avgVolumeForScore": 2310072
    },
    "ma_cross": {
      "ma20": 130.8645,
      "ma50": 123.9742,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 131.0795,
      "prevMa50": 123.6398,
      "spreadPct": 5.56,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 124.6797,
      "upper": 137.0493,
      "position": "上半部"
    },
    "rsi_short": 15.56,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.06
    }
  }
}

Raw metrics JSON

{
  "close": 131.14,
  "volume": 2443946,
  "changePercent": 0.41
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.